Oncolytics Biotech (ONCY) EV to EBITDA (2009 - 2026)
Oncolytics Biotech's (ONCY) quarterly EV to EBITDA came in at 12.19 in Q2 2026, up 17.03% year-over-year from 10.41 in Q2 2025, and down 1.4% quarter-over-quarter from 12.02 in Q3 2025.
Powered by 
Analysis
Oncolytics Biotech (ONCY) EV to EBITDA (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported EV to EBITDA for 18 consecutive years, with 12.19 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to EBITDA rose 17.03% year-over-year to 12.19 in Q2 2026; TTM through Jun 2026 was 3.8, a 31.19% decrease from a year earlier, with the FY2025 full-year figure at 3.09, down 29.08% from the prior year.
- EV to EBITDA was 12.19 for Q2 2026 at Oncolytics Biotech, down from 12.02 in the prior quarter.
- Over five years, EV to EBITDA peaked at 5.49 in Q2 2022 and troughed at 26.08 in Q4 2023.
- A 5-year average of 13.64 and a median of 12.19 in 2022 frame the typical range for EV to EBITDA.
- Across the five-year window, EV to EBITDA jumped 62.63% in 2022 and slumped 367.91% in 2023, its largest moves.
- Over 5 years, EV to EBITDA stood at 12.19 in 2022, then plunged by 114.0% to 26.08 in 2023, then surged by 58.86% to 10.73 in 2024, then decreased by 11.99% to 12.02 in 2025, then fell by 1.4% to 12.19 in 2026.
- The last three EV to EBITDA figures came in at 12.19 (Q2 2026), 12.02 (Q3 2025), and 14.69 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn |
| 10 | Oncolytics Biotech | 93.43 Mn | 93.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.19 |
| Sep 30, 2025 | -12.02 |
| Jun 30, 2025 | -14.69 |
| Dec 31, 2024 | -10.73 |
| Sep 30, 2024 | -7.29 |
| Jun 30, 2024 | -10.60 |
| Dec 31, 2023 | -26.08 |
| Sep 30, 2023 | -14.04 |
| Jun 30, 2023 | -25.67 |
| Dec 31, 2022 | -12.19 |
| Sep 30, 2022 | -12.70 |
| Jun 30, 2022 | -5.49 |
| Dec 31, 2021 | -7.16 |
| Sep 30, 2021 | -15.08 |
| Jun 30, 2021 | -14.68 |
| Dec 31, 2020 | -12.01 |
| Sep 30, 2020 | -2.11 |
| Jun 30, 2020 | -2.38 |
| Sep 30, 2019 | 0.67 |
| Jun 30, 2019 | -3.29 |